Cargando…
Diagnosing FSGS without kidney biopsy – a novel INF2-mutation in a family with ESRD of unknown origin
BACKGROUND: Patients on renal replacement therapy are often unaware of their underlying condition and hence suffer from so-called end-stage renal disease (ESRD) of unknown origin. However, an exact diagnosis is not only important for better estimating the prognosis, but also when preparing for kidne...
Autores principales: | Münch, Johannes, Grohmann, Maik, Lindner, Tom H., Bergmann, Carsten, Halbritter, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5062827/ https://www.ncbi.nlm.nih.gov/pubmed/27733133 http://dx.doi.org/10.1186/s12881-016-0336-9 |
Ejemplares similares
-
Clinical and Pathological Heterogeneity in FSGS due to INF2 Mutations
por: Morales-Alvarez, Martha Catalina, et al.
Publicado: (2022) -
Effective immunosuppressive management with belatacept and eculizumab in post-transplant aHUS due to a homozygous deletion of CFHR1/CFHR3 and the presence of CFH antibodies
por: Münch, Johannes, et al.
Publicado: (2017) -
Deleterious Impact of a Novel CFH Splice Site Variant in Atypical Hemolytic Uremic Syndrome
por: Schönauer, Ria, et al.
Publicado: (2019) -
Genetic mutational testing of Chinese children with familial hematuria with biopsy-proven FSGS
por: Li, Yongzhen, et al.
Publicado: (2018) -
The diagnostic value of native kidney biopsy in low grade, subnephrotic, and nephrotic range proteinuria: A retrospective cohort study
por: de Fallois, Jonathan, et al.
Publicado: (2022)